http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107496928-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
| filingDate | 2017-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107496928-B |
| titleOfInvention | Ursodeoxycholic acid dry suspension and preparation method thereof |
| abstract | The invention relates to ursodeoxycholic acid dry suspension and a preparation method thereof, and particularly belongs to the technical field of pharmaceutical preparations. The ursodeoxycholic acid dry suspension comprises ursodeoxycholic acid, a suspending agent, a thickening agent, a glidant and a flavoring agent, is suitable for children and adult patients with dysphagia, and has the in-vitro drug release performance consistent with that of imported products, namely YouSi. The development success of the ursodeoxycholic acid dry suspension is good news of children and dysphagia patients, and has a wide market prospect and clinical application necessity. |
| priorityDate | 2017-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 185.